-
1
-
-
77956281923
-
Neonatal outcomes of extremely preterm infants from the nichd neonatal research network
-
Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126: 443-456.
-
(2010)
Pediatrics
, vol.126
, pp. 443-456
-
-
Stoll, B.J.1
Hansen, N.I.2
Bell, E.F.3
-
2
-
-
35848952935
-
Chronic lung disease after premature birth
-
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-1955.
-
(2007)
N Engl J Med
, vol.357
, pp. 1946-1955
-
-
Baraldi, E.1
Filippone, M.2
-
3
-
-
0032706843
-
The new bpd: An arrest of lung development
-
Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
-
(1999)
Pediatr Res
, vol.46
, pp. 641-643
-
-
Jobe, A.J.1
-
4
-
-
84921430263
-
Early (,8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
-
Halliday HL, Ehrenkranz RA, Doyle LW. Early (,8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2010; 1: CD001146.
-
(2010)
Cochrane Database Syst Rev
, vol.1
-
-
Halliday, H.L.1
Ehrenkranz, R.A.2
Doyle, L.W.3
-
5
-
-
70349129941
-
Animal derived surfactant extract for treatment of respiratory distress syndrome
-
Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009; 2: CD007836.
-
(2009)
Cochrane Database Syst Rev
, vol.2
-
-
Seger, N.1
Soll, R.2
-
6
-
-
70349252005
-
Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease
-
Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124: e439-e449.
-
(2009)
Pediatrics
, vol.124
-
-
Vento, M.1
Moro, M.2
Escrig, R.3
-
7
-
-
0033600279
-
Vitamin a supplementation for extremely-low-birth-weight infants
-
Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 1999; 340: 1962-1968.
-
(1999)
N Engl J Med
, vol.340
, pp. 1962-1968
-
-
Tyson, J.E.1
Wright, L.L.2
Oh, W.3
-
8
-
-
33646681887
-
Caffeine therapy for apnea of prematurity
-
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112-2121.
-
(2006)
N Engl J Med
, vol.354
, pp. 2112-2121
-
-
Schmidt, B.1
Roberts, R.S.2
Davis, P.3
-
10
-
-
76749121781
-
Caffeine for apnea of prematurity trial: Benefits may vary in subgroups
-
Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr 2010; 156: 382-387.
-
(2010)
J Pediatr
, vol.156
, pp. 382-387
-
-
Davis, P.G.1
Schmidt, B.2
Roberts, R.S.3
-
11
-
-
70449526442
-
Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants
-
Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 2009; 168: 1491-1495.
-
(2009)
Eur J Pediatr
, vol.168
, pp. 1491-1495
-
-
Kassim, Z.1
Greenough, A.2
Rafferty, G.F.3
-
12
-
-
10744227545
-
Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress
-
Wagenaar GT, terHorst SA, van GastelenMA, et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic BiolMed 2004; 36: 782-801.
-
(2004)
Free Radic BiolMed
, vol.36
, pp. 782-801
-
-
Wagenaar, G.T.1
TerHorst, S.A.2
Van Gastelen, M.A.3
-
13
-
-
0031843337
-
Functional and pathological effects of prolonged hyperoxia in neonatal mice
-
Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275: L110-L117.
-
(1998)
Am J Physiol
, vol.275
-
-
Warner, B.B.1
Stuart, L.A.2
Papes, R.A.3
-
14
-
-
33745069841
-
Structural aspects of postnatal lung development-Alveolar formation and growth
-
Burri PH. Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 2006; 89: 313-322.
-
(2006)
Biol Neonate
, vol.89
, pp. 313-322
-
-
Burri, P.H.1
-
15
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative pcr and the 2-ddct method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001; 25: 402-408.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
16
-
-
0029999181
-
Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen
-
Han RN, Buch S, Tseu I, et al. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1996; 39: 921-929.
-
(1996)
Pediatr Res
, vol.39
, pp. 921-929
-
-
Han, R.N.1
Buch, S.2
Tseu, I.3
-
17
-
-
0034802186
-
Nonpeptide cxcr2 antagonist prevents neutrophil accumulation in hyperoxiaexposed newborn rats
-
Auten RL, Richardson RM, White JR, et al. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxiaexposed newborn rats. J Pharmacol Exp Ther 2001; 299: 90-95.
-
(2001)
J Pharmacol Exp Ther
, vol.299
, pp. 90-95
-
-
Auten, R.L.1
Richardson, R.M.2
White, J.R.3
-
18
-
-
0034521919
-
Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats
-
Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000; 162: 2316-2323.
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 2316-2323
-
-
Deng, H.1
Mason, S.N.2
Auten Jr., R.L.3
-
19
-
-
0033838904
-
Cytokine response during hyperoxia: Sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats
-
Ben-Ari J, Makhoul IR, Dorio RJ, et al. Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2000; 2: 365-369.
-
(2000)
Isr Med Assoc J
, vol.2
, pp. 365-369
-
-
Ben-Ari, J.1
Makhoul, I.R.2
Dorio, R.J.3
-
20
-
-
0029817281
-
Cytokines in chronic lung disease of prematurity
-
Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996; 155: Suppl. 2, S14-S17.
-
(1996)
Eur J Pediatr
, vol.155
, Issue.SUPPL. 2
-
-
Kotecha, S.1
-
21
-
-
33745845181
-
Inflammation and bronchopulmonary dysplasia: A continuing story
-
Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006; 11: 354-362.
-
(2006)
Semin Fetal Neonatal Med
, vol.11
, pp. 354-362
-
-
Speer, C.P.1
-
22
-
-
79951676230
-
Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine a2a receptor-independent mechanism
-
Li J, Li G, Hu JL, et al. Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism. Eur J Pharmacol 2011; 654: 295-303.
-
(2011)
Eur J Pharmacol
, vol.654
, pp. 295-303
-
-
Li, J.1
Li, G.2
Hu, J.L.3
-
23
-
-
1942432613
-
Respiratory disorders in preterm and term infants. In: Fanaroff aa, martin rj, eds. Neonatal-perinatal medicine. Diseases of the fetus and infant
-
Miller JM, Fanaroff AA, Martin Jr. Respiratory disorders in preterm and term infants. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. Diseases of the Fetus and Infant. Maryland Height, Mosby, 1997; pp. 1040-1065.
-
(1997)
Maryland Height, Mosby
, pp. 1040-1065
-
-
Miller, J.M.1
Fanaroff, A.A.2
Martin, J.R.3
-
25
-
-
60449103179
-
Caffeine modulates tnf-A production by cord blood monocytes: The role of adenosine receptors
-
Chavez-Valdez R, Wills-Karp M, Ahlawat R, et al. Caffeine modulates TNF-A production by cord blood monocytes: the role of adenosine receptors. Pediatr Res 2009; 65: 203-208.
-
(2009)
Pediatr Res
, vol.65
, pp. 203-208
-
-
Chavez-Valdez, R.1
Wills-Karp, M.2
Ahlawat, R.3
-
26
-
-
4143117971
-
Caffeine suppresses tnf-A production via activation of the cyclic amp/protein kinase a pathway
-
Horrigan LA, Kelly JP, Connor TJ. Caffeine suppresses TNF-A production via activation of the cyclic AMP/protein kinase A pathway. Int Immunopharmacol 2004; 4: 1409-1417.
-
(2004)
Int Immunopharmacol
, vol.4
, pp. 1409-1417
-
-
Horrigan, L.A.1
Kelly, J.P.2
Connor, T.J.3
-
27
-
-
38849133578
-
1, 3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism
-
Ohta A, Lukashev D, Jackson EK, et al. 1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J Immunol 2007; 179: 7431-7438.
-
(2007)
J Immunol
, vol.179
, pp. 7431-7438
-
-
Ohta, A.1
Lukashev, D.2
Jackson, E.K.3
-
28
-
-
0037191418
-
Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures
-
Kang SH, Lee YA, Won SJ, et al. Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. Neuroreport 2002; 13: 1945-1950.
-
(2002)
Neuroreport
, vol.13
, pp. 1945-1950
-
-
Kang, S.H.1
Lee, Y.A.2
Won, S.J.3
-
29
-
-
78649985801
-
Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants
-
Chavez Valdez R, Ahlawat R, Wills-Karp M, et al. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J Pediatr 2011; 158: 57-64.
-
(2011)
J Pediatr
, vol.158
, pp. 57-64
-
-
Chavez Valdez, R.1
Ahlawat, R.2
Wills-Karp, M.3
-
30
-
-
0021981599
-
Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat
-
Bortolotti A, Jiritano L, Bonati M. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat. Drug Metab Dispos 1985; 13: 227-231.
-
(1985)
Drug Metab Dispos
, vol.13
, pp. 227-231
-
-
Bortolotti, A.1
Jiritano, L.2
Bonati, M.3
-
32
-
-
0035209620
-
International union of pharmacology: Xxv. Nomenclature and classification of adenosine receptors
-
Fredholm BB, Ijzerman AP, Jacobson KA, et al. International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
-
(2001)
Pharmacol Rev
, vol.53
, pp. 527-552
-
-
Fredholm, B.B.1
Ijzerman, A.P.2
Jacobson, K.A.3
-
33
-
-
33644770260
-
Adenosine receptors as therapeutic targets
-
Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006; 5: 247-264.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 247-264
-
-
Jacobson, K.A.1
Gao, Z.G.2
-
35
-
-
79251568017
-
Distinct roles for the a2b adenosine receptor in acute and chronic stages of bleomycininduced lung injury
-
Zhou Y, Schneider DJ, Morschl E, et al. Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycininduced lung injury. J Immunol 2011; 186: 1097-1106.
-
(2011)
J Immunol
, vol.186
, pp. 1097-1106
-
-
Zhou, Y.1
Schneider, D.J.2
Morschl, E.3
|